Immune Checkpoint Inhibitor

Explore clinical trials studying Immune Checkpoint Inhibitor. Study availability and eligibility vary by location and protocol.

25 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Immune Checkpoint Inhibitor trial results

Active, not recruiting

NCT05383716

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Peking Union Medical College Hospital Beijing, China

Completed

NCT05848011

Conditions: Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, +17 more
Locations: United Medical Group Miami, Florida, United States

Orlando Health Cancer Institute Orlando, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View all 61 locations

Completed

NCT06007274

Conditions: Cancer, Cardiovascular Biomarkers, Immune Checkpoint Inhibitor, +1 more
Locations: Institut Mutualiste Montsouris Paris, France

Completed

NCT05675111

Conditions: Endocrine Toxicity, Immune Checkpoint Inhibitor
Locations: First Affiliated Hospital, Nanjing Medical University Nanjing, Jiangsu, China

Completed

NCT04470440

Conditions: Immune Checkpoint Inhibitor, Non Small Cell Lung Cancer Metastatic, Prognosis, +2 more
Locations: CHRU de Brest Brest, France